Promotional website intended for UK Healthcare Professionals only.
Please click here for the Lenzetto® Prescribing Information.

SAFETY AND TOLERABILITY OF LENZETTO®

Lenzetto® safety and tolerability information

In a study of 454 women who received Lenzetto®,
application site reactions appeared in just 1.3% of women1

Common reported adverse events (≥1/100 to <1/10)2

  • Headache
  • Abdominal pain
  • Nausea
  • Rash
  • Pruritus
  • Breast pain
  • Breast tenderness
  • Uterine/Vaginal bleeding including spotting
  • Metrorrhagia
  • Weight increase or decrease

Reasons for immediate withdrawal of therapy2

  • Jaundice or deterioration in liver function
  • Significant increase in blood pressure
  • New onset of migraine-type headache
  • Pregnancy

Contraindications2

  • Known, past or suspected breast cancer
  • Previous or current venous thromboembolism
  • Acute liver disease, or a history or liver disease as long as liver function tests have failed to return to normal
  • Known or suspected oestrogen-dependent malignant tumours
  • Known thrombophilic disorders
  • Porphyria
  • Undiagnosed genital bleeding
  • Active or recent arterial thromboembolic disease
  • Hypersensitivity to estradiol, ethanol or octisalate
  • Untreated endometrial hyperplasia
For the complete listing of precautions, risks and the adverse event profile, please consult the link to the Summary of Product Characteristics at the bottom of this page.
Lenzetto does not contain any ingredients derived from an animal source.
Disclaimer

You are now leaving Lenzetto.co.uk and will be directed to a website not owned by Gedeon Richter that contains further information on Lenzetto® (estradiol). Always refer to your GP or a Healthcare Professional.

Links to other websites are provided as a resource to our visitors.

Gedeon Richter accepts no responsibility for the content of other websites.

Disclaimer

You are now leaving Lenzetto.co.uk and will be directed to another Gedeon Richter hosted website that contains promotional information from Gedeon Richter.

Links to other websites are provided as a resource to our visitors.

NEW 20% MDS REBATE FOR DISPENSING DOCTORS
Gedeon Richter are offering a NEW 20% MDS rebate on Lenzetto® for dispensing doctors, when ordering via PSUK.
Use PIP codes:
414-9092 to order a single pack of Lenzetto®
414-9100 for a multi-pack (three units)